Axl is related to inflammation in hemodialysis patients.

BACKGROUND Hemodialysis (HD) patients often develop chronic inflammation, which is associated with an increased risk of cardiovascular complications and mortality. Axl and its ligand, growth arrest 6 (Gas6), have been reported to play key roles in regulating the immune response. However, the function of Axl in HD patients has not been clarified. METHODS In the present study, we enrolled 130 HD patients and 117 normal controls (NCs) and evaluated the levels of inflammatory markers, soluble Axl (sAxl), membrane Axl (mAxl), and Gas6 in all participants. The potential downstream cascades of Gas6-Axl signaling in HD patients were identified by quantitative real time polymerase chain reaction and western blotting. RESULTS The levels of inflammatory cytokines-tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ)-plasma sAxl, and Gas6, were significantly increased in HD patients compared to NCs. Additionally, sAxl was positively associated with the inflammatory factor, interleukin-6 (IL-6), in HD patients. Moreover, we found that mAxl in CD14+ mononuclear cells and CD19+ B cells was increased upon HD. Furthermore, we discovered that the metalloproteinase ADAM17, also called TACE, contributed to the cleavage of mAxl into sAxl, and not ADAM10, in the peripheral blood mononuclear cells (PBMCs) of HD patients. The upregulation of Gas6-mAxl signaling caused the activation of the STAT1-SOCS3 pathway in the PBMCs of HD patients. After two years follow-up, patients with lower sAxl levels had longer survival time than those with higher sAxl levels. CONCLUSION Our results suggest that Axl may play a significant role in systemic inflammation in HD patients.

• Publication year

  2021

• Venue

  Molecular Immunology

• Publication date

  2021-03-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.molimm.2021.02.024PMID 33667984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soluble AXL as a marker of disease progression and survival in melanoma

  2020cited by this paper
• The Pros1/Tyro3 axis protects against periodontitis by modulating STAT/SOCS signalling

  2019cited by this paper
• Oxidative Balance and Inflammation in Hemodialysis Patients: Biomarkers of Cardiovascular Risk?

  2019cited by this paper
• Chronic inflammation in end-stage renal disease and dialysis

  2018cited by this paper
• The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview

  2018cited by this paper
• Risk factors for mortality in patients undergoing hemodialysis: A systematic review and meta-analysis.

  2017cited by this paper
• Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.

  2016cited by this paper
• Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE.

  2016cited by this paper
• Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer

  2016cited by this paper
• Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in Juvenile-onset Systemic Lupus Erythematosus

  2015cited by this paper
• Growth Arrest-specific 6 Protein and Matrix Gla Protein in Hemodialysis Patients.

  2015cited by this paper
• Monocyte and plasma expression of TAM ligand and receptor in renal failure: Links to unregulated immunity and chronic inflammation.

  2015cited by this paper
• TAM Receptor–Dependent Regulation of SOCS3 and MAPKs Contributes to Proinflammatory Cytokine Downregulation following Chronic NOD2 Stimulation of Human Macrophages

  2015cited by this paper
• Diversification of TAM receptor function

  2014cited by this paper
• Different expression patterns and clinical significance of mAxl and sAxl in systemic lupus erythematosus

  2014cited by this paper
• Evaluation of plasma concentrations of homocysteine, IL-6, TNF-alpha, hs-CRP, and total antioxidant capacity in patients with end-stage renal failure.

  2014cited by this paper
• Increased MerTK expression in circulating innate immune cells of patients with septic shock

  2013cited by this paper
• Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure.

  2012cited by this paper
• IL-1β receptor antagonist reduces inflammation in hemodialysis patients.

  2011cited by this paper
• IL-1 (cid:1) Receptor Antagonist Reduces Inflammation in Hemodialysis Patients

  2011cited by this paper
• TAM receptors and the clearance of apoptotic cells

  2010cited by this paper
• Increased SOCS expression in peripheral blood mononuclear cells of end stage renal disease patients is related to inflammation and dialysis modality.

  2009cited by this paper
• Survival and Migration of Human Dendritic Cells Are Regulated by an IFN-α-Inducible Axl/Gas6 Pathway1

  2009cited by this paper
• The Immunological Genome Project: networks of gene expression in immune cells

  2008cited by this paper
• Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes.

  2008cited by this paper
• TAM receptors are pleiotropic inhibitors of the innate immune response.

  2007cited by this paper
• Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis

  2006cited by this paper
• Inflammatory syndrome in patients on hemodialysis.

  2006cited by this paper
• Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.

  2006cited by this paper
• Twist mediates suppression of inflammation by type I IFNs and Axl

  2006cited by this paper
• Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.

  2004cited by this paper
• Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment.

  2002cited by this paper
• Epidemiology of cardiovascular disease in chronic renal disease

  2000cited by this paper
• Epidemiology of cardiovascular disease in chronic renal disease.

  1998cited by this paper
• axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase

  1991cited by this paper

• C1632 protects against LPS-induced acute lung injury by regulating AXL-mediated MAPK/NF-κB signaling pathway.

  2025cites this paper
• Increased Cardiovascular Mortality in Hemodialysis: The Role of Chronic Inflammation, Complement Activation, and Non-Biocompatibility

  2025cites this paper
• Construction of an Antithrombotic and Anti-Inflammatory Polyethersulfone Membrane.

  2023cites this paper
• Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy

  2023cites this paper
• Three Oxidative Stress-Related Genes That Associate Endometrial Immune Cells Are Considered as Potential Biomarkers for the Prediction of Unexplained Recurrent Implantation Failure

  2022cites this paper
• AXL Inhibits Proinflammatory Factors to Relieve Rheumatoid Arthritis Pain by Regulating the TLR4/NF-κB Signaling Pathway

  2022cites this paper